Highlighted Research Trials and Studies
Go to CLINICALTRIALS.GOV for a more comprehenisive list of ongoing studies and trials.
Stanford Ophthalmology, Children's hospital of Philadelphia and Gilbert Family Foundation
| 2024
This study is seeking to learn how different eye tests and devices can…
Massachusetts's General Hospital
| 2024
If you or your child has NF1, and you don't go to an…
University of Wisconsin-Milwaukee
| 2023
By Dr. Bonnie Klein-Tasman
Dana-Farber/Boston Children's
| 2024
The Neurofibromatosis Type 1 Tumor Early Detection (NF1-TED) study will determine whether a…
CLOSED:
Mass General Brigham
| 2023
We want to learn more about your experiences looking for NF1 medical information…
NFlection Therapeutics | 2023
Ann & Robert H. Luries Childrens Hospital of Chicago
| 2023
By Carlos Prada, MD
Recruiting NF1 individuals with known Plexiform Neurofibromas
CLOSED:
John Hopkins Medicine
| 2023
By Carlos Romo, MD
Children and teens 19 years and younger.Adults 40 years and over.
Massachusetts General Hospital/Harvard
| 2022
By Julie Brewer
University of Wisconsin-Milwaukee
| 2021
By Bonnie Klein-Tasman, PhD
Recursion Pharmaceuticals Inc.
This is a parallel-group, two-staged, Phase 2/3, randomized, multi-center study to investigate the…
Massachusetts General Hospital/Harvard
| 2022
By Julie Brewer
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.